Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent

US Patent 7838513 · Granted Nov 23, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carbazole derivatives for the treatment of fibrotic diseases and related symptom2024
Carbazole derivatives for the treatment of fibrotic diseases and related symptom2021
Carbazole derivatives for the treatment of fibrotic diseases and related symptom2020
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
Pro-angiogenic peptides and peptide conjugates2018
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2017
Tricyclic compounds, compositions comprising them and uses thereof2016
Compositions capable of facilitating penetration across a biological barrier2012
Short peptides from the ‘2nd loop’ of 7 transmembrane receptor which selectively2010
Amino acid sequences capable of facilitating penetration across a biological bar2006
Methods of modulating G-protein-coupled receptor kinase-associated signal transd2006
Short peptides which selectively modulate the activity of serine/threonine kinas2004